Characteristic and clinical relevance of Candida mannan test in the diagnosis of probable invasive candidiasis

Medical Mycology

Volumn 52, Issue 5, 2014, Pages 460-469

  Chumpitazi, Bernabé F F ^a   Lebeau, Bernadette ^a   Faure Cognet, Odile ^a   Hamidfar Roy, Rebecca ^a   Timsit, Jean François ^a   Pavese, Patricia ^a   Thiebaut Bertrand, Anne ^a   Quesada, Jean Louis ^a   Pelloux, Hervé ^a   Pinel, Claudine ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

candidemia; invasive Candida infection; mannan; systematic review

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; FUNGAL POLYSACCHARIDE; MANNAN; MICAFUNGIN; VORICONAZOLE; DIAGNOSTIC KIT; FUNGUS ANTIBODY; FUNGUS ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDA COLONIZATION INDEX; CANDIDA GLABRATA; CANDIDA MANNAN TEST; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; FUNGAL COLONIZATION; HUMAN; INFANT; INVASIVE CANDIDIASIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEWBORN; PREDICTIVE VALUE; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; BLOOD; CANDIDA; CANDIDIASIS, INVASIVE; CASE CONTROL STUDY; DIAGNOSTIC KIT; IMMUNOLOGY; ISOLATION AND PURIFICATION; META ANALYSIS; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; RECEIVER OPERATING CHARACTERISTIC; VERY ELDERLY; YOUNG ADULT; BLOOD SAMPLING; CANDIDA ALBICANS; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FEVER; FUNGAL DETECTION; INFECTION RISK; NEUTROPHIL COUNT; NONHUMAN; SERODIAGNOSIS; SYSTEMATIC REVIEW; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; CANDIDA; CANDIDIASIS, INVASIVE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MANNANS; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; RETROSPECTIVE STUDIES; ROC CURVE; YOUNG ADULT;

CANDIDA;

EID: 84903196007     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1093/mmy/myu018     Document Type: Article

References (39)

1. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3: 685-702.
2. Azie N, Neofytos D, Pfaller M et al. The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. Diagn Microbiol Infect Dis 2012; 73: 293-300.
3. Eggimann P, Bille J, Marchetti O. Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care 2011; 1: 37.
4. Hong-Nguyen M, Wissel MC, Shields RK et al. Performance of Candida real-time polymerase chain reaction, p-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 2012; 54: 1240-1248.
5. Lunel FMV, Mennink-Kersten ASH, Ruegebrink D et al. Value of Candida serum markers in patients with invasive candidiasis after myeloablative chemotherapy. Diagn Microbiol Infect Dis 2009; 64: 408-415.
6. Takazono T, Izumikawa K, Nagayoshi Y et al. Evaluation of the Cica fungi Candida, a novel serum Candida mannan antigen kit, and its comparison with Cand-Tec in candidemia patients. Jpn J Infect Dis 2011; 64: 116-120.
7. Maubon D, Hamidfar-Roy R, Courby S et al. Therapeutic impact and diagnostic performance of multiplex PCR in patients with malignancies and suspected sepsis. J Infect 2010; 61: 335-342.
8. Mokaddas E, Khan ZU, Ahmad S, Nampoory MR, Burhamah M. Value of (1-3)-β-D-glucan, Candida mannan and Candida DNA detection in the diagnosis of candidaemia. Clin Microbiol Infect 2011; 17: 1549-1553.
9. White PL, Archer AE, Barnes RA. Comparison of non-culture-based methods for detection of systemic fungal infections, with an emphasis on invasive Candida infections. J Clin Microbiol 2005; 43: 2181-2187.
10. Lunel FMV, Donnelly JP, van der Lee HAL, Blijlevens NMA, Verweij PE. Performance of the new Platelia Candida Plus assays for the diagnosis of invasive Candida infection in patients undergoing myeloablative therapy. Med Mycol 2011; 49: 848-855.
11. Prella M, Bille J, Pugnale M et al. Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies. Diagn Microbiol Infect Dis 2005; 51: 95-101.
12. Del Bono V, Delfino E, Furfaro E et al. Clinical performance of the (1, 3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections. Clin Vaccine Immunol 2011; 18: 2113-2117.
13. Onishi A, Sugiyama D, Kogata Y et al. Diagnostic accuracy of serum 1, 3-β-D-glucan for Pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol 2012; 50: 7-15.
14. Shibata N, Kobayashi H, Suzuki S. Immunochemistry of pathogenic yeast, Candida species, focusing on mannan. Proc Jpn Acad Ser B Phys Biol Sci 2012; 88: 250-265.
15. Saijo S, Iwakura Y. Dectin-1 and dectin-2 in innate immunity against fungi. Int Immunol 2011; 23: 467-472.
16. Breier F, Oesterreicher C, Brugger S et al. Immunohistochem-istry with monoclonal antibody against Candida albicans man-nan antigen demonstrates cutaneous Candida granulomas as evidence of Candida sepsis in an immunosuppressed host. Dermatology 1997; 194: 293-296.
17. Mikulska M, Calandra T, Sanguinetti M et al. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care 2010; 14: R222.
18. Alam FF, Mustafa AS, Khan ZU. Comparative evaluation of (1, 3)-β-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infect Dis 2007; 7: 103.
19. Mokaddas E, Burhamah MH, Khan ZU, Ahmad S. Levels of (1→3)-β-D- glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida species. BMC Infect Dis 2010; 10: 292.
20. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
21. Ruhnke M, Rickerts V, Cornely OA et al. Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy. Mycoses 2011; 54: 279-310.
22. Fricker-Hidalgo H, Lebeau B, Pelloux H, Grillot R. Use of the BACTEC 9240 system with mycosis-IC/F blood culture bottles for detection of fungemia. J Clin Microbiol 2004; 42: 1855-1856.
23. Eloy O, Marque S, Mourvilliers B et al. Contribution of the Pittet's index, antigen assay, IgM, and total antibodies in the diagnosis of invasive candidiasis in intensive care unit. J Mycol Med 2006; 16: 113-118.
24. Arendrup MC, Sulim S, Holm A et al. Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol 2011; 49: 3300-3308.
25. Fujita S-I, Takamura T, Nagahara M, Hashimoto T. Evaluation of a newly developed down-flow immunoassay for detection of serum mannan antigens in patients with candidaemia. J Med Microbiol 2006; 55: 537-543.
26. Persat F, Topenot R, Piens MA et al. Evaluation of different commercial ELISA methods for the serodiagnosis of systemic candidosis. Mycoses 2002; 45: 455-460.
27. Ellis M, Al-Ramadi B, Bernsen R et al. Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever. J Med Microbiol 2009; 58: 606-615.
28. Sendid B, Jouault T, Coudriau R et al. Increased sensitivity of mannanemia detection tests by joint detection of a-and b-linked oligomannosides during experimental and human systemic can-didiasis. J Clin Microbiol 2004; 42: 164-171.
29. Sendid B, Tabouret M, Poirot JL et al. New enzyme immunoas-says for sensitive detection of circulating Candida albicans man-nan and antimannan antibodies: Useful combined test for diagnosis of systemic candidiasis. J Clin Microbiol 1999; 37: 1510-1517.
30. Oliveri S, Trovato L, Betta P, Romeo MG, Nicoletti G. Experience with the Platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients. Clin Microbiol Infect 2008; 14: 391-393.
31. Ostrosky-Zeichner L. Invasive mycoses: Diagnostic challenges. Am J Med 2012; 125: S14-S24.
32. Mora-Montes HM, Bader O, López-Romero E et al. Kex2 protease converts the endoplasmic reticulum alpha1, 2-mannosidase of Candida albicans into a soluble cytosolic form. Microbiology 2008; 154: 3782-3794.
33. Dariusz Szajda S, Waszkiewicz N, Stypułkowska A, Dadan J, Zwierz K. Lysosomal exoglycosidases in serum and urine of patients with pancreatic adenocarcinoma. Folia Histochem Cy-tobiol 2010; 48: 351-357.
34. Damiens S, Poissy J, François N et al. Mannose-binding lectin levels and variation during invasive candidiasis. J Clin Immunol 2012; 32: 1317-1323.
35. Schaffer T, Müller S, Flogerzi B et al. Anti-Saccharomyces cere-visiae mannan antibodies (ASCA) of Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans. Inflamm Bowel Dis 2007; 13: 1339-1346.
36. Mpofu CM, Campbell BJ, Subramanian S et al. Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn's disease. Gastroenterology 2007; 133: 1487-1498.
37. Nnalue NA, Weintraub A, Oscarson S, Lindberg AA. Cross-reactivity between the mannan of Candida species, Klebsiella K24 polysaccharide and Salmonella C1 and E O-antigens is mediated by a terminal non-reducing beta-mannosyl residue. Eur J Biochem. 1994; 220: 973-979.
38. Marot-Leblond A, Nail-Billaud S, Pilon F et al. Efficient diagnosis of vulvovaginal candidiasis by use of a new rapid im-munochromatography test. J Clin Microbiol 2009; 47: 3821-3825.
39. Matsui H, Hanaki H, Takahashi K et al. Rapid detection of vaginal Candida species by newly developed im-munochromatography. Clin Vaccine Immunol 2009; 16: 1366-1368.